Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 30, 2015, 34 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.00 to $87,499,988.94.

Highlighted Stocks Traded by Insiders:

Cantel Medical (CMN) - FREE Research Report

Krakauer Andrew A, who is Ceo at Cantel Medical, sold 11,660 shares at $48.72 on March 30, 2015. Following this transaction, the Ceo owned 171,913 shares meaning that the stake was reduced by 6.35% with the 11,660-share transaction.

The shares most recently traded at $47.98, down $0.74, or 1.55% since the insider transaction. Historical insider transactions for Cantel Medical go as follows:

  • 4-Week # shares sold: 42,204
  • 12-Week # shares sold: 42,204
  • 24-Week # shares sold: 182,344

The average volume for Cantel Medical has been 118,000 shares per day over the past 30 days. Cantel Medical has a market cap of $2.0 billion and is part of the health care sector and health services industry. Shares are up 11.49% year-to-date as of the close of trading on Monday.

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. The stock currently has a dividend yield of 0.21%. The company has a P/E ratio of 46.0. Currently, there is 1 analyst who rates Cantel Medical a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMN - FREE

TheStreet Quant Ratings rates Cantel Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cantel Medical Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Village Super Market (VLGEA) - FREE Research Report

Sumas William, who is Director at Village Super Market, sold 4,629 shares at $31.53 on March 30, 2015. Following this transaction, the Director owned 245,208 shares meaning that the stake was reduced by 1.85% with the 4,629-share transaction.

The shares most recently traded at $31.02, down $0.51, or 1.65% since the insider transaction. Historical insider transactions for Village Super Market go as follows:

  • 4-Week # shares sold: 59,765
  • 12-Week # shares sold: 89,156
  • 24-Week # shares sold: 177,675

The average volume for Village Super Market has been 17,700 shares per day over the past 30 days. Village Super Market has a market cap of $303.0 million and is part of the services sector and retail industry. Shares are up 14.47% year-to-date as of the close of trading on Monday.

Village Super Market, Inc., together with its subsidiaries, operates a chain of supermarkets in the United States. The stock currently has a dividend yield of 3.2%. The company has a P/E ratio of 22.0. Currently, there are no analysts who rate Village Super Market a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VLGEA - FREE

TheStreet Quant Ratings rates Village Super Market as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Village Super Market Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

State Auto Financial (STFC) - FREE Research Report

State Automobile Mutual Insurance Co, who is 10% Owner at State Auto Financial, bought 3,072 shares at $24.16 on March 30, 2015. Following this transaction, the 10% Owner owned 25.8 million shares meaning that the stake was boosted by 0.01% with the 3,072-share transaction.

The shares most recently traded at $23.87, down $0.29, or 1.23% since the insider transaction. Historical insider transactions for State Auto Financial go as follows:

  • 4-Week # shares bought: 48,838
  • 12-Week # shares bought: 100,422
  • 24-Week # shares bought: 203,726

The average volume for State Auto Financial has been 35,400 shares per day over the past 30 days. State Auto Financial has a market cap of $984.0 million and is part of the financial sector and insurance industry. Shares are up 9.32% year-to-date as of the close of trading on Monday.

State Auto Financial Corporation, through its subsidiaries, is engaged in writing personal, business, and specialty insurance products. The company operates through four segments: Personal insurance, Business insurance, Specialty insurance, and Investment operations. The stock currently has a dividend yield of 1.67%. The company has a P/E ratio of 9.2. Currently, there is 1 analyst who rates State Auto Financial a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on STFC - FREE

TheStreet Quant Ratings rates State Auto Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, compelling growth in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full State Auto Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null